TCL Archive In Brief: ACS Asks Removal Of Dollar Authorization Levels; FDA May Overrule Advisors On Estramustine November 23, 1979
TCL Archive ABMT Trials Unlikely To show Clean Benefit for Breast Cancer; Data Release Debated March 12, 1999
TCL Archive Supreme Court Decision Means FTC Scrutiny As Costly Oncology Drugs Go Off-Patent June 21, 2013